Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
Sofia EdinBjörn GyllingXingru LiÅsa StenbergAnna Löfgren-BurströmCarl ZingmarkBethany van GuelpenIngrid LjuslinderAgnes LingRichard PalmqvistPublished in: British journal of cancer (2023)
A combined evaluation of MSI status, KRAS and BRAF mutational status, and immune infiltration (cytotoxic T cells) may provide important insights to prognosis and response to immunotherapy in CRC.
Keyphrases